Mental Healthcare in Older Adults With Schizophrenia

Schizophrenia Clinical Trial

— CSA  

Official title:

The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02884739
• Other study ID #: PN08001
• Status: Active, not recruiting
• Phase: N/A
• First received: August 26, 2016
• Last updated: September 1, 2016
• Start date: January 2010
• Est. completion date: July 2018

Study information

• Verified date: September 2016
• Source: CHU de Reims
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertés
• Study type: Observational

Clinical Trial Summary

As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.

Description:

Evaluate prospectively over 5 years, the rates and causes of mortality in a cohort of schizophrenic patients older than 60 years, followed by adult psychiatry sectors, compared to those patients matched for sex and age and monitored by the same sectors for a chronic psychiatric disorder other than schizophrenia

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 685
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Men or women aged than 60 years with a diagnosis of schizophrenia, according to the DSM-IV criteria

• Men or women aged than 60 years with chronic psychiatric disorder other than schizophrenia

• Patients consenting to participate to the study

• Patients enrolled in the national healthcare insurance program

Exclusion Criteria:

-Disease affecting the central nervous system

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Chronic Psychiatric Disorder
• Mental Disorders
• Problem Behavior
• Schizophrenia

Intervention

Other:
• Data collection

Locations

Country	Name	City	State
France	Chu de Reims	Reims

Sponsors (1)

Lead Sponsor	Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

References & Publications (1)

Raucher-Chéné D, Hoertel N, Béra-Potelle C, Terrien S, Barrière S, Da Rin D, Tran E, Cuervo-Lombard C, Portefaix C, Limosin F. Mental healthcare in older adults with schizophrenia: results from 118 French public psychiatric departments. Int Psychogeriatr. 2015 Oct;27(10):1749-50. doi: 10.1017/S1041610215001064. Epub 2015 Jul 6. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death	Death of any causes	5 years	No